Instrument Inactif

Autres langues Biofermin Pharmaceutical Co., Ltd.

Actions

27/07/21	Taisho Pharmaceutical Holdings Co., Ltd. completed the acquisition of remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers.
14/05/21	Taisho Pharmaceutical Holdings Co., Ltd. executed a share exchange agreement to acquire remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers for ¥14.8 billion.
18/09/17	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index
01/02/17	Taisho and Takeda Terminate Agreement on the Distribution of Biofermin Pharmaceutical's OTC Drugs and Quasi-Drugs
19/09/16	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index
21/09/15	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index
31/07/13	Takeda Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. Agrees Conduct Domestic Transactions in Relation to Sale of Products Manufactured by Biofermin Pharmaceutical
31/07/13	Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. from Takeda Pharmaceutical Company Limited.
25/07/13	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to Japan TOPIX Index